Salona Global Medical Device Corporation
Символ: SGMD.V
TSX
0.22
CADПазарна цена днес
-15.8062
Съотношение P/E
0.2483
Коефициент PEG
17.24M
MRK Cap
- 0.00%
Доходност на DIV
Salona Global Medical Device Corporation (SGMD-V) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 7.93 | 8.1 | 7.6 | 9.2 | |||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0.5 | 0.8 | |||||||||
balance-sheet.row.net-receivables | 41.01 | 7 | 0.1 | 0.1 | |||||||||
balance-sheet.row.inventory | 40.77 | 5 | 0 | 0 | |||||||||
balance-sheet.row.other-current-assets | 1.35 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-current-assets | 91.07 | 20 | 13.1 | 9.3 | |||||||||
balance-sheet.row.property-plant-equipment-net | 52.96 | 5.4 | 0 | 0 | |||||||||
balance-sheet.row.goodwill | 57.63 | 9.8 | 0 | 0 | |||||||||
balance-sheet.row.intangible-assets | 39.21 | 6.9 | 0 | 0 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 96.84 | 16.8 | 0 | 0 | |||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.other-non-current-assets | 3.79 | 0.5 | 0 | 0 | |||||||||
balance-sheet.row.total-non-current-assets | 153.6 | 22.6 | 0 | 0 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 244.66 | 42.7 | 13.1 | 9.3 | |||||||||
balance-sheet.row.account-payables | 24.08 | 2.9 | 0.5 | 0.4 | |||||||||
balance-sheet.row.short-term-debt | 54.11 | 5.9 | 0 | 0 | |||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.long-term-debt-total | 30.11 | 4.6 | 0 | 0 | |||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 2.43 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 60.37 | 13.6 | 6 | 0 | |||||||||
balance-sheet.row.total-non-current-liabilities | 32.53 | 6.4 | 0 | 0 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 32.34 | 4.2 | 0 | 0 | |||||||||
balance-sheet.row.total-liab | 179.29 | 29.5 | 6.5 | 0.4 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 214.07 | 38.5 | 31.1 | 31.1 | |||||||||
balance-sheet.row.retained-earnings | -199.71 | -33.4 | -29 | -26.9 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 6.44 | 1 | 0.9 | 1.4 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 44.56 | 7 | 3.6 | 3.4 | |||||||||
balance-sheet.row.total-stockholders-equity | 65.37 | 13.2 | 6.6 | 9 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 244.66 | 42.7 | 13.1 | 9.3 | |||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-equity | 65.37 | 13.2 | 6.6 | 9 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 244.66 | - | - | - | |||||||||
Total Investments | 0 | 0 | 0.5 | 0.8 | |||||||||
balance-sheet.row.total-debt | 84.22 | 10.5 | 0 | 0 | |||||||||
balance-sheet.row.net-debt | 76.29 | 2.5 | -7.1 | -8.3 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -1.32 | -4.4 | -2.7 | -1.8 | ||||||||
cash-flows.row.depreciation-and-amortization | 3.99 | 0.8 | 0.8 | 0.1 | ||||||||
cash-flows.row.deferred-income-tax | 0.03 | -0.1 | -0.1 | 0 | ||||||||
cash-flows.row.stock-based-compensation | 1.38 | 1.2 | 0.2 | 0 | ||||||||
cash-flows.row.change-in-working-capital | 0.31 | -0.2 | 1.3 | 1.3 | ||||||||
cash-flows.row.account-receivables | -1.97 | -2.1 | -2.1 | 0 | ||||||||
cash-flows.row.inventory | 3.06 | 0.2 | 0.2 | 0 | ||||||||
cash-flows.row.account-payables | 1.42 | 0 | 0 | 0 | ||||||||
cash-flows.row.other-working-capital | -2.2 | 1.6 | 3.1 | 0 | ||||||||
cash-flows.row.other-non-cash-items | -5.32 | -1.1 | -0.5 | 0.3 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -0.92 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.5 | -0.1 | -0.1 | 0 | ||||||||
cash-flows.row.acquisitions-net | -6.02 | -5.1 | -5.1 | 0 | ||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -0.4 | -0.9 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0.5 | 0.4 | 0 | ||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 5.1 | 0 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | -6.53 | -4.6 | 0.1 | -0.9 | ||||||||
cash-flows.row.debt-repayment | -1.12 | -2.5 | -2.5 | 0 | ||||||||
cash-flows.row.common-stock-issued | 0 | 4.3 | 4.3 | 0 | ||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.other-financing-activites | 3.71 | 2.2 | 3.7 | 0 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 2.61 | 3.9 | 5.4 | 0 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.16 | -0.1 | -0.4 | 0.1 | ||||||||
cash-flows.row.net-change-in-cash | -4.68 | -4.4 | 4.2 | -1 | ||||||||
cash-flows.row.cash-at-end-of-period | 9.29 | 8.1 | 12.5 | 8.3 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 13.96 | 12.5 | 8.3 | 9.3 | ||||||||
cash-flows.row.operating-cash-flow | -0.92 | -3.7 | -1 | -0.1 | ||||||||
cash-flows.row.capital-expenditure | -0.5 | -0.1 | -0.1 | 0 | ||||||||
cash-flows.row.free-cash-flow | -1.43 | -3.8 | -1 | -0.1 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 57.45 | 18.3 | 0 | 0.4 | ||||||||
income-statement-row.row.cost-of-revenue | 36.96 | 12.4 | 12.4 | 0.4 | ||||||||
income-statement-row.row.gross-profit | 20.49 | 6 | -12.4 | 0 | ||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||
income-statement-row.row.selling-general-administrative | 16.14 | - | - | - | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.other-expenses | 2.98 | -3.8 | -1.6 | 0 | ||||||||
income-statement-row.row.operating-expenses | 27.1 | 6.6 | 1 | 1.7 | ||||||||
income-statement-row.row.cost-and-expenses | 64.06 | 18.9 | 1 | 2.1 | ||||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.interest-expense | 1.6 | 0.4 | 0.4 | 0 | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.total-other-income-expensenet | 6.87 | -3.5 | -1.6 | 0 | ||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||
income-statement-row.row.other-operating-expenses | 2.98 | -3.8 | -1.6 | 0 | ||||||||
income-statement-row.row.total-operating-expenses | 6.87 | -3.5 | -1.6 | 0 | ||||||||
income-statement-row.row.interest-expense | 1.6 | 0.4 | 0.4 | 0 | ||||||||
income-statement-row.row.depreciation-and-amortization | 3.99 | 0.8 | 0.8 | 0.1 | ||||||||
income-statement-row.row.ebitda-caps | -0.61 | - | - | - | ||||||||
income-statement-row.row.operating-income | -4.6 | -4.5 | -1 | -1.7 | ||||||||
income-statement-row.row.income-before-tax | -1.33 | -4.5 | -2.7 | -1.8 | ||||||||
income-statement-row.row.income-tax-expense | -0.01 | -0.1 | -0.1 | 0.6 | ||||||||
income-statement-row.row.net-income | -1.32 | -4.4 | -2.7 | -2.3 |
Често задавани въпроси
Какво е Salona Global Medical Device Corporation (SGMD.V) общи активи?
Salona Global Medical Device Corporation (SGMD.V) общите активи са 42681612.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 36222564.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е -0.015.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е -0.015.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -0.023.
Какъв е общият приход на предприятието?
Общият приход е -0.080.
Каква е Salona Global Medical Device Corporation (SGMD.V) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е -4372019.000.
Какъв е общият дълг на фирмата?
Общият дълг е 10533056.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 6570013.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 1052647.000.